Online edition of India's National Newspaper
Sunday, Apr 11, 2010
ePaper | Mobile/PDA Version
Google



Front Page
News: ePaper | Front Page | National | Tamil Nadu | Andhra Pradesh | Karnataka | Kerala | New Delhi | Other States | International | Business | Sport | Miscellaneous | Engagements |
Advts:
Retail Plus | Classifieds | Jobs | Obituary |

Front Page Printer Friendly Page   Send this Article to a Friend

Neglected tropical diseases afflict millions in India

Narayan Lakshman

Government should promote low-cost drugs, vaccines


Elephantiasis is costing India close to

$1 billion per annum

Much potential for India-U.S. cooperation in developing new drugs and vaccines for hookworm


Washington DC:Neglected tropical diseases such as hookworm infection and lymphatic filariasis that affect over 100 million people in India have simple, low-cost drug and vaccine treatments that governments need to promote, according to Peter Hotez, Distinguished Research Professor and Chair of the Department of Microbiology, Immunology, and Tropical Medicine, George Washington University.

Speaking to The Hindu after a seminar on “Control of the Neglected Tropical Diseases: Innovative Approaches and Role in U.S. Foreign Policy,” Mr. Hotez said there were approximately 70 million cases of hookworm infection and 30 million cases of lymphatic filariasis, also known as elephantiasis, in India with the latter costing the country close to $1 billion per year.

To highlight the extent of the disease in India, Mr. Hotez said that towards the end of his life, Mohandas Gandhi suffered from a hookworm infection, a disease caused by blood-feeding worms in the intestine and associated with severe anaemia, lethargy, and fatigue.

“The fact that Gandhi's vigorous efforts to wage peace in India may have been slowed because of hookworms is only one of the more dramatic examples of the deep connection between medical health and the promotion of international peace and security,” said Mr. Hotez.

He also linked the need to combat these diseases with U.S. foreign policy imperatives, pointing out that there was an “extraordinary opportunity” for the U.S. to improve treatment of these infections in Islamic countries such as Pakistan and Syria and also in other states with nuclear interests, such as India, China and North Korea — where neglected tropical diseases had “devastating consequences” for many.

In particular, Mr. Hotez said there was much potential for the U.S. to cooperate with India in further developing new drugs and vaccines for hookworm infection and Leishmaniasis, a disease with extremely high infection rates in Bihar.

He said that even in some developing countries the ratio of public expenditure on nuclear projects to neglected tropical diseases was of the order of magnitude of 10,000 to one.

He added that even putting aside a small part of this military expenditure towards the treatment of diseases like hookworm would constitute an enormous anti-poverty step.

Printer friendly page  
Send this article to Friends by E-Mail



Front Page

News: ePaper | Front Page | National | Tamil Nadu | Andhra Pradesh | Karnataka | Kerala | New Delhi | Other States | International | Business | Sport | Miscellaneous | Engagements |
Advts:
Retail Plus | Classifieds | Jobs | Obituary | Updates: Breaking News |


Chandraayan I


News Update



The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | The Hindu ePaper | Business Line | Business Line ePaper | Sportstar | Frontline | Publications | eBooks | Images | Ergo | Home |

Copyright © 2010, The Hindu. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu